Natural killer cell subsets differentially reject embryonic stem cells based on licensing

Jessica Perez-Cunningham, Erik Ames, Rachel C. Smith, Anna K. Peter, Ridhima Naidu, Jan Nolta, William J Murphy

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Embryonic stem cells (ESC) and induced pluripotent stem cells provide great promise to the future of medicine. Because immune rejection represents a major obstacle to the success of all stem cell-based therapies, many recent studies have sought to determine the key immune mediators involved in ESC rejection. The role of natural killer (NK) cells and specifically the role of NK cell licensing is not well understood in ESC rejection. Methods: Mouse or human ESCs were subjected to cytotoxicity assays involving their respective species-matched activated NK cells. Mouse ESCs were then transplanted to allogeneic recipients after depletion of NK cell subsets in the host. ESC engraftment was analyzed by bioluminescent imaging. Results: Depletion of all NK cells in vivo resulted in the greatest amount of ESC engraftment, confirming a role for NK cells in ESC rejection. Importantly, depletion of the Ly49C/I or Ly49G2 NK cell subsets resulted in differential ESC engraftment and rejection. This indicates that NK cell rejection of allogeneic ESC is highly differential based on the presence of licensed NK cells. Blocking NKG2D in vitro resulted in less killing of mESC by allogeneic NK cells, indicating NKG2D is a likely mechanism for NK-mediated killing of mESC. Conclusions: In this study, we show that expression of inhibitory Ly49s correlates with the ability of NK cells to kill murine ESC in an NKG2D-dependent manner. This further suggests that the rejection of similar stem cell transplants in humans will be dependent upon the presence of licensed NK cells.

Original languageEnglish (US)
Pages (from-to)992-998
Number of pages7
JournalTransplantation
Volume97
Issue number10
DOIs
StatePublished - May 27 2014

Fingerprint

Licensure
Embryonic Stem Cells
Natural Killer Cells
Stem Cells
Induced Pluripotent Stem Cells
Cell- and Tissue-Based Therapy
Medicine
Transplants

Keywords

  • Embryonic stem cells
  • Licensing
  • NK cells
  • Stem cell transplantation
  • Tolerance

ASJC Scopus subject areas

  • Transplantation

Cite this

Natural killer cell subsets differentially reject embryonic stem cells based on licensing. / Perez-Cunningham, Jessica; Ames, Erik; Smith, Rachel C.; Peter, Anna K.; Naidu, Ridhima; Nolta, Jan; Murphy, William J.

In: Transplantation, Vol. 97, No. 10, 27.05.2014, p. 992-998.

Research output: Contribution to journalArticle

Perez-Cunningham, Jessica ; Ames, Erik ; Smith, Rachel C. ; Peter, Anna K. ; Naidu, Ridhima ; Nolta, Jan ; Murphy, William J. / Natural killer cell subsets differentially reject embryonic stem cells based on licensing. In: Transplantation. 2014 ; Vol. 97, No. 10. pp. 992-998.
@article{5f8ebd5fa87a4c9b9c1a695f05dd1c87,
title = "Natural killer cell subsets differentially reject embryonic stem cells based on licensing",
abstract = "Background: Embryonic stem cells (ESC) and induced pluripotent stem cells provide great promise to the future of medicine. Because immune rejection represents a major obstacle to the success of all stem cell-based therapies, many recent studies have sought to determine the key immune mediators involved in ESC rejection. The role of natural killer (NK) cells and specifically the role of NK cell licensing is not well understood in ESC rejection. Methods: Mouse or human ESCs were subjected to cytotoxicity assays involving their respective species-matched activated NK cells. Mouse ESCs were then transplanted to allogeneic recipients after depletion of NK cell subsets in the host. ESC engraftment was analyzed by bioluminescent imaging. Results: Depletion of all NK cells in vivo resulted in the greatest amount of ESC engraftment, confirming a role for NK cells in ESC rejection. Importantly, depletion of the Ly49C/I or Ly49G2 NK cell subsets resulted in differential ESC engraftment and rejection. This indicates that NK cell rejection of allogeneic ESC is highly differential based on the presence of licensed NK cells. Blocking NKG2D in vitro resulted in less killing of mESC by allogeneic NK cells, indicating NKG2D is a likely mechanism for NK-mediated killing of mESC. Conclusions: In this study, we show that expression of inhibitory Ly49s correlates with the ability of NK cells to kill murine ESC in an NKG2D-dependent manner. This further suggests that the rejection of similar stem cell transplants in humans will be dependent upon the presence of licensed NK cells.",
keywords = "Embryonic stem cells, Licensing, NK cells, Stem cell transplantation, Tolerance",
author = "Jessica Perez-Cunningham and Erik Ames and Smith, {Rachel C.} and Peter, {Anna K.} and Ridhima Naidu and Jan Nolta and Murphy, {William J}",
year = "2014",
month = "5",
day = "27",
doi = "10.1097/TP.0000000000000063",
language = "English (US)",
volume = "97",
pages = "992--998",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Natural killer cell subsets differentially reject embryonic stem cells based on licensing

AU - Perez-Cunningham, Jessica

AU - Ames, Erik

AU - Smith, Rachel C.

AU - Peter, Anna K.

AU - Naidu, Ridhima

AU - Nolta, Jan

AU - Murphy, William J

PY - 2014/5/27

Y1 - 2014/5/27

N2 - Background: Embryonic stem cells (ESC) and induced pluripotent stem cells provide great promise to the future of medicine. Because immune rejection represents a major obstacle to the success of all stem cell-based therapies, many recent studies have sought to determine the key immune mediators involved in ESC rejection. The role of natural killer (NK) cells and specifically the role of NK cell licensing is not well understood in ESC rejection. Methods: Mouse or human ESCs were subjected to cytotoxicity assays involving their respective species-matched activated NK cells. Mouse ESCs were then transplanted to allogeneic recipients after depletion of NK cell subsets in the host. ESC engraftment was analyzed by bioluminescent imaging. Results: Depletion of all NK cells in vivo resulted in the greatest amount of ESC engraftment, confirming a role for NK cells in ESC rejection. Importantly, depletion of the Ly49C/I or Ly49G2 NK cell subsets resulted in differential ESC engraftment and rejection. This indicates that NK cell rejection of allogeneic ESC is highly differential based on the presence of licensed NK cells. Blocking NKG2D in vitro resulted in less killing of mESC by allogeneic NK cells, indicating NKG2D is a likely mechanism for NK-mediated killing of mESC. Conclusions: In this study, we show that expression of inhibitory Ly49s correlates with the ability of NK cells to kill murine ESC in an NKG2D-dependent manner. This further suggests that the rejection of similar stem cell transplants in humans will be dependent upon the presence of licensed NK cells.

AB - Background: Embryonic stem cells (ESC) and induced pluripotent stem cells provide great promise to the future of medicine. Because immune rejection represents a major obstacle to the success of all stem cell-based therapies, many recent studies have sought to determine the key immune mediators involved in ESC rejection. The role of natural killer (NK) cells and specifically the role of NK cell licensing is not well understood in ESC rejection. Methods: Mouse or human ESCs were subjected to cytotoxicity assays involving their respective species-matched activated NK cells. Mouse ESCs were then transplanted to allogeneic recipients after depletion of NK cell subsets in the host. ESC engraftment was analyzed by bioluminescent imaging. Results: Depletion of all NK cells in vivo resulted in the greatest amount of ESC engraftment, confirming a role for NK cells in ESC rejection. Importantly, depletion of the Ly49C/I or Ly49G2 NK cell subsets resulted in differential ESC engraftment and rejection. This indicates that NK cell rejection of allogeneic ESC is highly differential based on the presence of licensed NK cells. Blocking NKG2D in vitro resulted in less killing of mESC by allogeneic NK cells, indicating NKG2D is a likely mechanism for NK-mediated killing of mESC. Conclusions: In this study, we show that expression of inhibitory Ly49s correlates with the ability of NK cells to kill murine ESC in an NKG2D-dependent manner. This further suggests that the rejection of similar stem cell transplants in humans will be dependent upon the presence of licensed NK cells.

KW - Embryonic stem cells

KW - Licensing

KW - NK cells

KW - Stem cell transplantation

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=84901269125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901269125&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000000063

DO - 10.1097/TP.0000000000000063

M3 - Article

VL - 97

SP - 992

EP - 998

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -